nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—Betamethasone—multiple sclerosis	0.139	0.336	CrCtD
Fluticasone furoate—Dexamethasone—multiple sclerosis	0.139	0.336	CrCtD
Fluticasone furoate—Triamcinolone—multiple sclerosis	0.135	0.328	CrCtD
Fluticasone furoate—NR3C1—Methylprednisolone—multiple sclerosis	0.0381	0.169	CbGbCtD
Fluticasone furoate—NR3C1—Triamcinolone—multiple sclerosis	0.0289	0.128	CbGbCtD
Fluticasone furoate—NR3C1—Betamethasone—multiple sclerosis	0.0248	0.11	CbGbCtD
Fluticasone furoate—NR3C1—Prednisolone—multiple sclerosis	0.0244	0.108	CbGbCtD
Fluticasone furoate—NR3C1—Prednisone—multiple sclerosis	0.0231	0.102	CbGbCtD
Fluticasone furoate—NR3C1—Dexamethasone—multiple sclerosis	0.0144	0.0639	CbGbCtD
Fluticasone furoate—ABCB1—Methylprednisolone—multiple sclerosis	0.00887	0.0394	CbGbCtD
Fluticasone furoate—CYP3A4—Fingolimod—multiple sclerosis	0.00825	0.0366	CbGbCtD
Fluticasone furoate—ABCB1—Mitoxantrone—multiple sclerosis	0.00647	0.0287	CbGbCtD
Fluticasone furoate—ABCB1—Betamethasone—multiple sclerosis	0.00577	0.0256	CbGbCtD
Fluticasone furoate—ABCB1—Prednisolone—multiple sclerosis	0.00569	0.0252	CbGbCtD
Fluticasone furoate—ABCB1—Prednisone—multiple sclerosis	0.00537	0.0238	CbGbCtD
Fluticasone furoate—CYP3A4—Methylprednisolone—multiple sclerosis	0.00531	0.0236	CbGbCtD
Fluticasone furoate—CYP3A4—Triamcinolone—multiple sclerosis	0.00403	0.0179	CbGbCtD
Fluticasone furoate—CYP3A4—Mitoxantrone—multiple sclerosis	0.00388	0.0172	CbGbCtD
Fluticasone furoate—Flumethasone Pivalate—Methylprednisolone—multiple sclerosis	0.00368	0.0115	CrCrCtD
Fluticasone furoate—Flumethasone Pivalate—Dexamethasone—multiple sclerosis	0.00362	0.0114	CrCrCtD
Fluticasone furoate—Flumethasone Pivalate—Betamethasone—multiple sclerosis	0.00362	0.0114	CrCrCtD
Fluticasone furoate—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.00356	0.0112	CrCrCtD
Fluticasone furoate—Halobetasol Propionate—Methylprednisolone—multiple sclerosis	0.00356	0.0112	CrCrCtD
Fluticasone furoate—Difluprednate—Methylprednisolone—multiple sclerosis	0.00356	0.0112	CrCrCtD
Fluticasone furoate—Flumethasone Pivalate—Triamcinolone—multiple sclerosis	0.00354	0.0111	CrCrCtD
Fluticasone furoate—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.0035	0.011	CrCrCtD
Fluticasone furoate—Halobetasol Propionate—Betamethasone—multiple sclerosis	0.0035	0.011	CrCrCtD
Fluticasone furoate—Halobetasol Propionate—Dexamethasone—multiple sclerosis	0.0035	0.011	CrCrCtD
Fluticasone furoate—Difluprednate—Betamethasone—multiple sclerosis	0.0035	0.011	CrCrCtD
Fluticasone furoate—Difluprednate—Dexamethasone—multiple sclerosis	0.0035	0.011	CrCrCtD
Fluticasone furoate—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.0035	0.011	CrCrCtD
Fluticasone furoate—CYP3A4—Betamethasone—multiple sclerosis	0.00346	0.0153	CbGbCtD
Fluticasone furoate—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00342	0.0107	CrCrCtD
Fluticasone furoate—Difluprednate—Triamcinolone—multiple sclerosis	0.00342	0.0107	CrCrCtD
Fluticasone furoate—Halobetasol Propionate—Triamcinolone—multiple sclerosis	0.00342	0.0107	CrCrCtD
Fluticasone furoate—CYP3A4—Prednisolone—multiple sclerosis	0.00341	0.0151	CbGbCtD
Fluticasone furoate—ABCB1—Dexamethasone—multiple sclerosis	0.00335	0.0149	CbGbCtD
Fluticasone furoate—Clocortolone—Methylprednisolone—multiple sclerosis	0.00335	0.0105	CrCrCtD
Fluticasone furoate—Fluocinonide—Methylprednisolone—multiple sclerosis	0.00335	0.0105	CrCrCtD
Fluticasone furoate—Beclomethasone—Dexamethasone—multiple sclerosis	0.00329	0.0103	CrCrCtD
Fluticasone furoate—Clocortolone—Betamethasone—multiple sclerosis	0.00329	0.0103	CrCrCtD
Fluticasone furoate—Fluocinonide—Betamethasone—multiple sclerosis	0.00329	0.0103	CrCrCtD
Fluticasone furoate—Clocortolone—Dexamethasone—multiple sclerosis	0.00329	0.0103	CrCrCtD
Fluticasone furoate—Beclomethasone—Betamethasone—multiple sclerosis	0.00329	0.0103	CrCrCtD
Fluticasone furoate—Fluocinonide—Dexamethasone—multiple sclerosis	0.00329	0.0103	CrCrCtD
Fluticasone furoate—Fluocortolone—Methylprednisolone—multiple sclerosis	0.00325	0.0102	CrCrCtD
Fluticasone furoate—CYP3A4—Prednisone—multiple sclerosis	0.00322	0.0143	CbGbCtD
Fluticasone furoate—Fluocinonide—Triamcinolone—multiple sclerosis	0.00322	0.0101	CrCrCtD
Fluticasone furoate—Clocortolone—Triamcinolone—multiple sclerosis	0.00322	0.0101	CrCrCtD
Fluticasone furoate—Beclomethasone—Triamcinolone—multiple sclerosis	0.00322	0.0101	CrCrCtD
Fluticasone furoate—Fluocortolone—Betamethasone—multiple sclerosis	0.0032	0.01	CrCrCtD
Fluticasone furoate—Fluocortolone—Dexamethasone—multiple sclerosis	0.0032	0.01	CrCrCtD
Fluticasone furoate—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	0.00316	0.00992	CrCrCtD
Fluticasone furoate—Fluocortolone—Triamcinolone—multiple sclerosis	0.00313	0.00981	CrCrCtD
Fluticasone furoate—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	0.00311	0.00977	CrCrCtD
Fluticasone furoate—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	0.00311	0.00977	CrCrCtD
Fluticasone furoate—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	0.00304	0.00954	CrCrCtD
Fluticasone furoate—Amcinonide—Betamethasone—multiple sclerosis	0.00303	0.0095	CrCrCtD
Fluticasone furoate—Amcinonide—Dexamethasone—multiple sclerosis	0.00303	0.0095	CrCrCtD
Fluticasone furoate—Flunisolide—Methylprednisolone—multiple sclerosis	0.003	0.00941	CrCrCtD
Fluticasone furoate—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.003	0.00941	CrCrCtD
Fluticasone furoate—Diflorasone—Methylprednisolone—multiple sclerosis	0.003	0.00941	CrCrCtD
Fluticasone furoate—Beclomethasone—Prednisolone—multiple sclerosis	0.00298	0.00936	CrCrCtD
Fluticasone furoate—Clocortolone—Prednisolone—multiple sclerosis	0.00298	0.00936	CrCrCtD
Fluticasone furoate—Fluocortolone—Prednisone—multiple sclerosis	0.00297	0.00931	CrCrCtD
Fluticasone furoate—Amcinonide—Triamcinolone—multiple sclerosis	0.00296	0.00929	CrCrCtD
Fluticasone furoate—Diflorasone—Dexamethasone—multiple sclerosis	0.00295	0.00926	CrCrCtD
Fluticasone furoate—Diflorasone—Betamethasone—multiple sclerosis	0.00295	0.00926	CrCrCtD
Fluticasone furoate—Flunisolide—Betamethasone—multiple sclerosis	0.00295	0.00926	CrCrCtD
Fluticasone furoate—Flunisolide—Dexamethasone—multiple sclerosis	0.00295	0.00926	CrCrCtD
Fluticasone furoate—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.00295	0.00926	CrCrCtD
Fluticasone furoate—Clobetasol propionate—Betamethasone—multiple sclerosis	0.00295	0.00926	CrCrCtD
Fluticasone furoate—Paramethasone—Methylprednisolone—multiple sclerosis	0.00292	0.00917	CrCrCtD
Fluticasone furoate—Fluocortolone—Prednisolone—multiple sclerosis	0.0029	0.00909	CrCrCtD
Fluticasone furoate—Flunisolide—Triamcinolone—multiple sclerosis	0.00288	0.00905	CrCrCtD
Fluticasone furoate—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.00288	0.00905	CrCrCtD
Fluticasone furoate—Diflorasone—Triamcinolone—multiple sclerosis	0.00288	0.00905	CrCrCtD
Fluticasone furoate—Paramethasone—Betamethasone—multiple sclerosis	0.00288	0.00903	CrCrCtD
Fluticasone furoate—Paramethasone—Dexamethasone—multiple sclerosis	0.00288	0.00903	CrCrCtD
Fluticasone furoate—Desoximetasone—Methylprednisolone—multiple sclerosis	0.00285	0.00895	CrCrCtD
Fluticasone furoate—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	0.00282	0.00884	CrCrCtD
Fluticasone furoate—Paramethasone—Triamcinolone—multiple sclerosis	0.00281	0.00882	CrCrCtD
Fluticasone furoate—Amcinonide—Prednisone—multiple sclerosis	0.00281	0.00881	CrCrCtD
Fluticasone furoate—Desoximetasone—Betamethasone—multiple sclerosis	0.00281	0.00881	CrCrCtD
Fluticasone furoate—Desoximetasone—Dexamethasone—multiple sclerosis	0.00281	0.00881	CrCrCtD
Fluticasone furoate—Fluorometholone—Methylprednisolone—multiple sclerosis	0.00278	0.00874	CrCrCtD
Fluticasone furoate—Mometasone—Methylprednisolone—multiple sclerosis	0.00278	0.00874	CrCrCtD
Fluticasone furoate—Triamcinolone—Methylprednisolone—multiple sclerosis	0.00278	0.00874	CrCrCtD
Fluticasone furoate—Fluprednidene Acetate—Methylprednisolone—multiple sclerosis	0.00278	0.00874	CrCrCtD
Fluticasone furoate—Desoximetasone—Triamcinolone—multiple sclerosis	0.00274	0.0086	CrCrCtD
Fluticasone furoate—Amcinonide—Prednisolone—multiple sclerosis	0.00274	0.0086	CrCrCtD
Fluticasone furoate—Fluprednidene Acetate—Dexamethasone—multiple sclerosis	0.00274	0.0086	CrCrCtD
Fluticasone furoate—Triamcinolone—Betamethasone—multiple sclerosis	0.00274	0.0086	CrCrCtD
Fluticasone furoate—Fluorometholone—Dexamethasone—multiple sclerosis	0.00274	0.0086	CrCrCtD
Fluticasone furoate—Fluorometholone—Betamethasone—multiple sclerosis	0.00274	0.0086	CrCrCtD
Fluticasone furoate—Fluprednidene Acetate—Betamethasone—multiple sclerosis	0.00274	0.0086	CrCrCtD
Fluticasone furoate—Mometasone—Dexamethasone—multiple sclerosis	0.00274	0.0086	CrCrCtD
Fluticasone furoate—Mometasone—Betamethasone—multiple sclerosis	0.00274	0.0086	CrCrCtD
Fluticasone furoate—Triamcinolone—Dexamethasone—multiple sclerosis	0.00274	0.0086	CrCrCtD
Fluticasone furoate—Clobetasol propionate—Prednisone—multiple sclerosis	0.00274	0.00858	CrCrCtD
Fluticasone furoate—Diflorasone—Prednisone—multiple sclerosis	0.00274	0.00858	CrCrCtD
Fluticasone furoate—Flunisolide—Prednisone—multiple sclerosis	0.00274	0.00858	CrCrCtD
Fluticasone furoate—Dexamethasone—Methylprednisolone—multiple sclerosis	0.00272	0.00854	CrCrCtD
Fluticasone furoate—Betamethasone—Methylprednisolone—multiple sclerosis	0.00272	0.00854	CrCrCtD
Fluticasone furoate—ABCB1—Methotrexate—multiple sclerosis	0.0027	0.012	CbGbCtD
Fluticasone furoate—Betamethasone—Dexamethasone—multiple sclerosis	0.00268	0.0084	CrCrCtD
Fluticasone furoate—Dexamethasone—Betamethasone—multiple sclerosis	0.00268	0.0084	CrCrCtD
Fluticasone furoate—Fluprednidene Acetate—Triamcinolone—multiple sclerosis	0.00268	0.0084	CrCrCtD
Fluticasone furoate—Fluorometholone—Triamcinolone—multiple sclerosis	0.00268	0.0084	CrCrCtD
Fluticasone furoate—Mometasone—Triamcinolone—multiple sclerosis	0.00268	0.0084	CrCrCtD
Fluticasone furoate—Diflorasone—Prednisolone—multiple sclerosis	0.00267	0.00838	CrCrCtD
Fluticasone furoate—Flunisolide—Prednisolone—multiple sclerosis	0.00267	0.00838	CrCrCtD
Fluticasone furoate—Clobetasol propionate—Prednisolone—multiple sclerosis	0.00267	0.00838	CrCrCtD
Fluticasone furoate—Paramethasone—Prednisone—multiple sclerosis	0.00267	0.00837	CrCrCtD
Fluticasone furoate—Dexamethasone—Triamcinolone—multiple sclerosis	0.00262	0.00821	CrCrCtD
Fluticasone furoate—Betamethasone—Triamcinolone—multiple sclerosis	0.00262	0.00821	CrCrCtD
Fluticasone furoate—Paramethasone—Prednisolone—multiple sclerosis	0.0026	0.00817	CrCrCtD
Fluticasone furoate—Desoximetasone—Prednisone—multiple sclerosis	0.0026	0.00817	CrCrCtD
Fluticasone furoate—Fluorometholone—Prednisone—multiple sclerosis	0.00254	0.00797	CrCrCtD
Fluticasone furoate—Fluprednidene Acetate—Prednisone—multiple sclerosis	0.00254	0.00797	CrCrCtD
Fluticasone furoate—Mometasone—Prednisone—multiple sclerosis	0.00254	0.00797	CrCrCtD
Fluticasone furoate—Triamcinolone—Prednisone—multiple sclerosis	0.00254	0.00797	CrCrCtD
Fluticasone furoate—Desoximetasone—Prednisolone—multiple sclerosis	0.00254	0.00797	CrCrCtD
Fluticasone furoate—Betamethasone—Prednisone—multiple sclerosis	0.00248	0.00779	CrCrCtD
Fluticasone furoate—Dexamethasone—Prednisone—multiple sclerosis	0.00248	0.00779	CrCrCtD
Fluticasone furoate—Fluprednidene Acetate—Prednisolone—multiple sclerosis	0.00248	0.00778	CrCrCtD
Fluticasone furoate—Fluorometholone—Prednisolone—multiple sclerosis	0.00248	0.00778	CrCrCtD
Fluticasone furoate—Triamcinolone—Prednisolone—multiple sclerosis	0.00248	0.00778	CrCrCtD
Fluticasone furoate—Mometasone—Prednisolone—multiple sclerosis	0.00248	0.00778	CrCrCtD
Fluticasone furoate—Dexamethasone—Prednisolone—multiple sclerosis	0.00242	0.0076	CrCrCtD
Fluticasone furoate—Betamethasone—Prednisolone—multiple sclerosis	0.00242	0.0076	CrCrCtD
Fluticasone furoate—CYP3A4—Dexamethasone—multiple sclerosis	0.00201	0.00892	CbGbCtD
Fluticasone furoate—Candida albicans infection—Triamcinolone—multiple sclerosis	0.00189	0.0455	CcSEcCtD
Fluticasone furoate—Nasal burning—Triamcinolone—multiple sclerosis	0.0017	0.0409	CcSEcCtD
Fluticasone furoate—Posterior subcapsular cataract—Prednisolone—multiple sclerosis	0.00125	0.0301	CcSEcCtD
Fluticasone furoate—Posterior subcapsular cataract—Dexamethasone—multiple sclerosis	0.00104	0.0252	CcSEcCtD
Fluticasone furoate—Posterior subcapsular cataract—Betamethasone—multiple sclerosis	0.00104	0.0252	CcSEcCtD
Fluticasone furoate—Nasal irritation—Triamcinolone—multiple sclerosis	0.00103	0.0247	CcSEcCtD
Fluticasone furoate—Growth retardation—Methylprednisolone—multiple sclerosis	0.000782	0.0188	CcSEcCtD
Fluticasone furoate—Cataract subcapsular—Prednisolone—multiple sclerosis	0.000742	0.0179	CcSEcCtD
Fluticasone furoate—Growth retardation—Betamethasone—multiple sclerosis	0.000712	0.0171	CcSEcCtD
Fluticasone furoate—Growth retardation—Dexamethasone—multiple sclerosis	0.000712	0.0171	CcSEcCtD
Fluticasone furoate—Cataract subcapsular—Triamcinolone—multiple sclerosis	0.000682	0.0164	CcSEcCtD
Fluticasone furoate—Cataract subcapsular—Methylprednisolone—multiple sclerosis	0.000681	0.0164	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Fingolimod—multiple sclerosis	0.000653	0.0157	CcSEcCtD
Fluticasone furoate—Nasal discomfort—Triamcinolone—multiple sclerosis	0.000623	0.015	CcSEcCtD
Fluticasone furoate—Growth retardation—Prednisone—multiple sclerosis	0.00062	0.0149	CcSEcCtD
Fluticasone furoate—Cataract subcapsular—Dexamethasone—multiple sclerosis	0.000619	0.0149	CcSEcCtD
Fluticasone furoate—Cataract subcapsular—Betamethasone—multiple sclerosis	0.000619	0.0149	CcSEcCtD
Fluticasone furoate—Cataract subcapsular—Prednisone—multiple sclerosis	0.000539	0.013	CcSEcCtD
Fluticasone furoate—Blood glucose increased—Mitoxantrone—multiple sclerosis	0.000461	0.0111	CcSEcCtD
Fluticasone furoate—Migraine—Fingolimod—multiple sclerosis	0.000452	0.0109	CcSEcCtD
Fluticasone furoate—Impaired healing—Prednisolone—multiple sclerosis	0.000448	0.0108	CcSEcCtD
Fluticasone furoate—Intraocular pressure increased—Prednisolone—multiple sclerosis	0.00044	0.0106	CcSEcCtD
Fluticasone furoate—Impaired healing—Triamcinolone—multiple sclerosis	0.000412	0.00992	CcSEcCtD
Fluticasone furoate—Impaired healing—Methylprednisolone—multiple sclerosis	0.000411	0.00989	CcSEcCtD
Fluticasone furoate—Intraocular pressure increased—Triamcinolone—multiple sclerosis	0.000405	0.00975	CcSEcCtD
Fluticasone furoate—Intraocular pressure increased—Methylprednisolone—multiple sclerosis	0.000404	0.00973	CcSEcCtD
Fluticasone furoate—Bronchitis—Fingolimod—multiple sclerosis	0.000382	0.0092	CcSEcCtD
Fluticasone furoate—Impaired healing—Dexamethasone—multiple sclerosis	0.000374	0.009	CcSEcCtD
Fluticasone furoate—Impaired healing—Betamethasone—multiple sclerosis	0.000374	0.009	CcSEcCtD
Fluticasone furoate—Intraocular pressure increased—Betamethasone—multiple sclerosis	0.000367	0.00885	CcSEcCtD
Fluticasone furoate—Intraocular pressure increased—Dexamethasone—multiple sclerosis	0.000367	0.00885	CcSEcCtD
Fluticasone furoate—Sinus congestion—Triamcinolone—multiple sclerosis	0.000358	0.00862	CcSEcCtD
Fluticasone furoate—Candida infection—Cladribine—multiple sclerosis	0.000343	0.00826	CcSEcCtD
Fluticasone furoate—Impaired healing—Prednisone—multiple sclerosis	0.000325	0.00784	CcSEcCtD
Fluticasone furoate—Intraocular pressure increased—Prednisone—multiple sclerosis	0.00032	0.0077	CcSEcCtD
Fluticasone furoate—Menorrhagia—Mitoxantrone—multiple sclerosis	0.000319	0.00768	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Fingolimod—multiple sclerosis	0.000313	0.00753	CcSEcCtD
Fluticasone furoate—Eye disorder—Fingolimod—multiple sclerosis	0.000297	0.00716	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Fingolimod—multiple sclerosis	0.000287	0.0069	CcSEcCtD
Fluticasone furoate—Impaired healing—Methotrexate—multiple sclerosis	0.000272	0.00655	CcSEcCtD
Fluticasone furoate—Back pain—Fingolimod—multiple sclerosis	0.000268	0.00645	CcSEcCtD
Fluticasone furoate—Glaucoma—Prednisolone—multiple sclerosis	0.000257	0.00619	CcSEcCtD
Fluticasone furoate—Ulcer—Mitoxantrone—multiple sclerosis	0.000249	0.00601	CcSEcCtD
Fluticasone furoate—Palpitations—Fingolimod—multiple sclerosis	0.000245	0.00589	CcSEcCtD
Fluticasone furoate—Cough—Fingolimod—multiple sclerosis	0.000242	0.00582	CcSEcCtD
Fluticasone furoate—Glaucoma—Triamcinolone—multiple sclerosis	0.000236	0.0057	CcSEcCtD
Fluticasone furoate—Glaucoma—Methylprednisolone—multiple sclerosis	0.000236	0.00568	CcSEcCtD
Fluticasone furoate—Infection—Fingolimod—multiple sclerosis	0.000224	0.00541	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Fingolimod—multiple sclerosis	0.000222	0.00534	CcSEcCtD
Fluticasone furoate—Glaucoma—Dexamethasone—multiple sclerosis	0.000215	0.00517	CcSEcCtD
Fluticasone furoate—Glaucoma—Betamethasone—multiple sclerosis	0.000215	0.00517	CcSEcCtD
Fluticasone furoate—Herpes simplex—Prednisolone—multiple sclerosis	0.00021	0.00506	CcSEcCtD
Fluticasone furoate—Dyspnoea—Fingolimod—multiple sclerosis	0.000201	0.00485	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Cladribine—multiple sclerosis	0.000195	0.0047	CcSEcCtD
Fluticasone furoate—Epistaxis—Cladribine—multiple sclerosis	0.000189	0.00456	CcSEcCtD
Fluticasone furoate—Ulcer—Triamcinolone—multiple sclerosis	0.000188	0.00453	CcSEcCtD
Fluticasone furoate—Cataract—Triamcinolone—multiple sclerosis	0.000187	0.00451	CcSEcCtD
Fluticasone furoate—Glaucoma—Prednisone—multiple sclerosis	0.000187	0.0045	CcSEcCtD
Fluticasone furoate—Pharyngitis—Cladribine—multiple sclerosis	0.000179	0.00431	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Cladribine—multiple sclerosis	0.000177	0.00427	CcSEcCtD
Fluticasone furoate—Herpes simplex—Betamethasone—multiple sclerosis	0.000175	0.00422	CcSEcCtD
Fluticasone furoate—Herpes simplex—Dexamethasone—multiple sclerosis	0.000175	0.00422	CcSEcCtD
Fluticasone furoate—Ulcer—Dexamethasone—multiple sclerosis	0.000171	0.00411	CcSEcCtD
Fluticasone furoate—Ulcer—Betamethasone—multiple sclerosis	0.000171	0.00411	CcSEcCtD
Fluticasone furoate—Candida infection—Triamcinolone—multiple sclerosis	0.00017	0.00409	CcSEcCtD
Fluticasone furoate—Cataract—Betamethasone—multiple sclerosis	0.00017	0.00409	CcSEcCtD
Fluticasone furoate—Cataract—Dexamethasone—multiple sclerosis	0.00017	0.00409	CcSEcCtD
Fluticasone furoate—Eye disorder—Cladribine—multiple sclerosis	0.000168	0.00406	CcSEcCtD
Fluticasone furoate—Immune system disorder—Cladribine—multiple sclerosis	0.000163	0.00392	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Cladribine—multiple sclerosis	0.000162	0.00391	CcSEcCtD
Fluticasone furoate—Diarrhoea—Fingolimod—multiple sclerosis	0.000155	0.00372	CcSEcCtD
Fluticasone furoate—Back pain—Cladribine—multiple sclerosis	0.000152	0.00366	CcSEcCtD
Fluticasone furoate—Fluticasone Propionate—PGR—multiple sclerosis	0.000151	0.311	CrCbGaD
Fluticasone furoate—Dizziness—Fingolimod—multiple sclerosis	0.000149	0.0036	CcSEcCtD
Fluticasone furoate—Ulcer—Prednisone—multiple sclerosis	0.000149	0.00358	CcSEcCtD
Fluticasone furoate—Visual disturbance—Prednisolone—multiple sclerosis	0.000148	0.00357	CcSEcCtD
Fluticasone furoate—Cataract—Prednisone—multiple sclerosis	0.000148	0.00356	CcSEcCtD
Fluticasone furoate—Headache—Fingolimod—multiple sclerosis	0.000142	0.00341	CcSEcCtD
Fluticasone furoate—Betamethasone—PGR—multiple sclerosis	0.000138	0.285	CrCbGaD
Fluticasone furoate—Cough—Cladribine—multiple sclerosis	0.000137	0.0033	CcSEcCtD
Fluticasone furoate—Immune system disorder—Azathioprine—multiple sclerosis	0.000132	0.00319	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Azathioprine—multiple sclerosis	0.000132	0.00318	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Mitoxantrone—multiple sclerosis	0.000128	0.00309	CcSEcCtD
Fluticasone furoate—Herpes simplex—Methotrexate—multiple sclerosis	0.000128	0.00307	CcSEcCtD
Fluticasone furoate—Infection—Cladribine—multiple sclerosis	0.000127	0.00307	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Cladribine—multiple sclerosis	0.000126	0.00303	CcSEcCtD
Fluticasone furoate—Ulcer—Methotrexate—multiple sclerosis	0.000124	0.00299	CcSEcCtD
Fluticasone furoate—Visual disturbance—Dexamethasone—multiple sclerosis	0.000124	0.00298	CcSEcCtD
Fluticasone furoate—Visual disturbance—Betamethasone—multiple sclerosis	0.000124	0.00298	CcSEcCtD
Fluticasone furoate—Hyperkinesia—Prednisone—multiple sclerosis	0.000123	0.00296	CcSEcCtD
Fluticasone furoate—Pharyngitis—Mitoxantrone—multiple sclerosis	0.000118	0.00283	CcSEcCtD
Fluticasone furoate—Triamcinolone—BCHE—multiple sclerosis	0.000116	0.238	CrCbGaD
Fluticasone furoate—Migraine—Dexamethasone—multiple sclerosis	0.000115	0.00278	CcSEcCtD
Fluticasone furoate—Migraine—Betamethasone—multiple sclerosis	0.000115	0.00278	CcSEcCtD
Fluticasone furoate—Dyspnoea—Cladribine—multiple sclerosis	0.000114	0.00275	CcSEcCtD
Fluticasone furoate—Bronchitis—Triamcinolone—multiple sclerosis	0.000107	0.00259	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Prednisolone—multiple sclerosis	0.000105	0.00254	CcSEcCtD
Fluticasone furoate—Infection—Azathioprine—multiple sclerosis	0.000103	0.00249	CcSEcCtD
Fluticasone furoate—Urticaria—Cladribine—multiple sclerosis	0.000102	0.00245	CcSEcCtD
Fluticasone furoate—Body temperature increased—Cladribine—multiple sclerosis	0.000101	0.00244	CcSEcCtD
Fluticasone furoate—Back pain—Mitoxantrone—multiple sclerosis	9.98e-05	0.0024	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Triamcinolone—multiple sclerosis	9.68e-05	0.00233	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Cladribine—multiple sclerosis	9.44e-05	0.00227	CcSEcCtD
Fluticasone furoate—Epistaxis—Triamcinolone—multiple sclerosis	9.39e-05	0.00226	CcSEcCtD
Fluticasone furoate—Visual impairment—Prednisolone—multiple sclerosis	9.37e-05	0.00226	CcSEcCtD
Fluticasone furoate—Visual disturbance—Methotrexate—multiple sclerosis	9.01e-05	0.00217	CcSEcCtD
Fluticasone furoate—Cough—Mitoxantrone—multiple sclerosis	9e-05	0.00217	CcSEcCtD
Fluticasone furoate—Pharyngitis—Triamcinolone—multiple sclerosis	8.87e-05	0.00214	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Dexamethasone—multiple sclerosis	8.78e-05	0.00212	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Betamethasone—multiple sclerosis	8.78e-05	0.00212	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Methylprednisolone—multiple sclerosis	8.77e-05	0.00211	CcSEcCtD
Fluticasone furoate—Diarrhoea—Cladribine—multiple sclerosis	8.76e-05	0.00211	CcSEcCtD
Fluticasone furoate—Visual impairment—Methylprednisolone—multiple sclerosis	8.6e-05	0.00207	CcSEcCtD
Fluticasone furoate—Dizziness—Cladribine—multiple sclerosis	8.47e-05	0.00204	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Mitoxantrone—multiple sclerosis	8.42e-05	0.00203	CcSEcCtD
Fluticasone furoate—Infection—Mitoxantrone—multiple sclerosis	8.36e-05	0.00201	CcSEcCtD
Fluticasone furoate—Eye disorder—Methylprednisolone—multiple sclerosis	8.34e-05	0.00201	CcSEcCtD
Fluticasone furoate—Body temperature increased—Azathioprine—multiple sclerosis	8.23e-05	0.00198	CcSEcCtD
Fluticasone furoate—Rash—Cladribine—multiple sclerosis	8.08e-05	0.00195	CcSEcCtD
Fluticasone furoate—Dermatitis—Cladribine—multiple sclerosis	8.07e-05	0.00194	CcSEcCtD
Fluticasone furoate—Immune system disorder—Methylprednisolone—multiple sclerosis	8.06e-05	0.00194	CcSEcCtD
Fluticasone furoate—Dexamethasone—PGR—multiple sclerosis	8.04e-05	0.166	CrCbGaD
Fluticasone furoate—Mediastinal disorder—Methylprednisolone—multiple sclerosis	8.04e-05	0.00194	CcSEcCtD
Fluticasone furoate—Headache—Cladribine—multiple sclerosis	8.02e-05	0.00193	CcSEcCtD
Fluticasone furoate—Visual impairment—Betamethasone—multiple sclerosis	7.82e-05	0.00188	CcSEcCtD
Fluticasone furoate—Visual impairment—Dexamethasone—multiple sclerosis	7.82e-05	0.00188	CcSEcCtD
Fluticasone furoate—Angioedema—Prednisolone—multiple sclerosis	7.73e-05	0.00186	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Azathioprine—multiple sclerosis	7.67e-05	0.00185	CcSEcCtD
Fluticasone furoate—Nausea—Cladribine—multiple sclerosis	7.61e-05	0.00183	CcSEcCtD
Fluticasone furoate—Eye disorder—Dexamethasone—multiple sclerosis	7.58e-05	0.00183	CcSEcCtD
Fluticasone furoate—Eye disorder—Betamethasone—multiple sclerosis	7.58e-05	0.00183	CcSEcCtD
Fluticasone furoate—Back pain—Triamcinolone—multiple sclerosis	7.53e-05	0.00181	CcSEcCtD
Fluticasone furoate—Dyspnoea—Mitoxantrone—multiple sclerosis	7.51e-05	0.00181	CcSEcCtD
Fluticasone furoate—NR3C1—Endoderm Differentiation—HHEX—multiple sclerosis	7.4e-05	0.0543	CbGpPWpGaD
Fluticasone furoate—Diarrhoea—Azathioprine—multiple sclerosis	7.13e-05	0.00172	CcSEcCtD
Fluticasone furoate—Angioedema—Triamcinolone—multiple sclerosis	7.11e-05	0.00171	CcSEcCtD
Fluticasone furoate—Angioedema—Methylprednisolone—multiple sclerosis	7.1e-05	0.00171	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Prednisone—multiple sclerosis	6.94e-05	0.00167	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Prednisolone—multiple sclerosis	6.91e-05	0.00166	CcSEcCtD
Fluticasone furoate—Dizziness—Azathioprine—multiple sclerosis	6.89e-05	0.00166	CcSEcCtD
Fluticasone furoate—Cough—Triamcinolone—multiple sclerosis	6.79e-05	0.00164	CcSEcCtD
Fluticasone furoate—Urticaria—Mitoxantrone—multiple sclerosis	6.69e-05	0.00161	CcSEcCtD
Fluticasone furoate—Body temperature increased—Mitoxantrone—multiple sclerosis	6.66e-05	0.0016	CcSEcCtD
Fluticasone furoate—Eye disorder—Prednisone—multiple sclerosis	6.6e-05	0.00159	CcSEcCtD
Fluticasone furoate—Rash—Azathioprine—multiple sclerosis	6.57e-05	0.00158	CcSEcCtD
Fluticasone furoate—Dermatitis—Azathioprine—multiple sclerosis	6.56e-05	0.00158	CcSEcCtD
Fluticasone furoate—Headache—Azathioprine—multiple sclerosis	6.52e-05	0.00157	CcSEcCtD
Fluticasone furoate—Angioedema—Dexamethasone—multiple sclerosis	6.45e-05	0.00155	CcSEcCtD
Fluticasone furoate—Angioedema—Betamethasone—multiple sclerosis	6.45e-05	0.00155	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Methotrexate—multiple sclerosis	6.39e-05	0.00154	CcSEcCtD
Fluticasone furoate—Immune system disorder—Prednisone—multiple sclerosis	6.38e-05	0.00154	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Triamcinolone—multiple sclerosis	6.35e-05	0.00153	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	6.34e-05	0.00153	CcSEcCtD
Fluticasone furoate—Infection—Triamcinolone—multiple sclerosis	6.31e-05	0.00152	CcSEcCtD
Fluticasone furoate—Infection—Methylprednisolone—multiple sclerosis	6.3e-05	0.00152	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Methylprednisolone—multiple sclerosis	6.22e-05	0.0015	CcSEcCtD
Fluticasone furoate—Epistaxis—Methotrexate—multiple sclerosis	6.2e-05	0.00149	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Mitoxantrone—multiple sclerosis	6.2e-05	0.00149	CcSEcCtD
Fluticasone furoate—Nausea—Azathioprine—multiple sclerosis	6.19e-05	0.00149	CcSEcCtD
Fluticasone furoate—Pharyngitis—Methotrexate—multiple sclerosis	5.86e-05	0.00141	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Dexamethasone—multiple sclerosis	5.76e-05	0.00139	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Betamethasone—multiple sclerosis	5.76e-05	0.00139	CcSEcCtD
Fluticasone furoate—Diarrhoea—Mitoxantrone—multiple sclerosis	5.76e-05	0.00139	CcSEcCtD
Fluticasone furoate—Infection—Betamethasone—multiple sclerosis	5.73e-05	0.00138	CcSEcCtD
Fluticasone furoate—Infection—Dexamethasone—multiple sclerosis	5.73e-05	0.00138	CcSEcCtD
Fluticasone furoate—Visual impairment—Methotrexate—multiple sclerosis	5.69e-05	0.00137	CcSEcCtD
Fluticasone furoate—Dyspnoea—Triamcinolone—multiple sclerosis	5.66e-05	0.00136	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Dexamethasone—multiple sclerosis	5.65e-05	0.00136	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Betamethasone—multiple sclerosis	5.65e-05	0.00136	CcSEcCtD
Fluticasone furoate—Agitation—Prednisone—multiple sclerosis	5.65e-05	0.00136	CcSEcCtD
Fluticasone furoate—Angioedema—Prednisone—multiple sclerosis	5.62e-05	0.00135	CcSEcCtD
Fluticasone furoate—Eye disorder—Methotrexate—multiple sclerosis	5.52e-05	0.00133	CcSEcCtD
Fluticasone furoate—Urticaria—Prednisolone—multiple sclerosis	5.49e-05	0.00132	CcSEcCtD
Fluticasone furoate—Immune system disorder—Methotrexate—multiple sclerosis	5.33e-05	0.00128	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Methotrexate—multiple sclerosis	5.32e-05	0.00128	CcSEcCtD
Fluticasone furoate—Rash—Mitoxantrone—multiple sclerosis	5.31e-05	0.00128	CcSEcCtD
Fluticasone furoate—Dermatitis—Mitoxantrone—multiple sclerosis	5.3e-05	0.00128	CcSEcCtD
Fluticasone furoate—Headache—Mitoxantrone—multiple sclerosis	5.27e-05	0.00127	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Prednisolone—multiple sclerosis	5.09e-05	0.00123	CcSEcCtD
Fluticasone furoate—Urticaria—Triamcinolone—multiple sclerosis	5.05e-05	0.00122	CcSEcCtD
Fluticasone furoate—Urticaria—Methylprednisolone—multiple sclerosis	5.03e-05	0.00121	CcSEcCtD
Fluticasone furoate—Body temperature increased—Triamcinolone—multiple sclerosis	5.02e-05	0.00121	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Prednisone—multiple sclerosis	5.02e-05	0.00121	CcSEcCtD
Fluticasone furoate—Nausea—Mitoxantrone—multiple sclerosis	5e-05	0.0012	CcSEcCtD
Fluticasone furoate—Infection—Prednisone—multiple sclerosis	4.99e-05	0.0012	CcSEcCtD
Fluticasone furoate—Back pain—Methotrexate—multiple sclerosis	4.97e-05	0.0012	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Prednisone—multiple sclerosis	4.92e-05	0.00119	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Triamcinolone—multiple sclerosis	4.68e-05	0.00113	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Methylprednisolone—multiple sclerosis	4.67e-05	0.00112	CcSEcCtD
Fluticasone furoate—Urticaria—Dexamethasone—multiple sclerosis	4.58e-05	0.0011	CcSEcCtD
Fluticasone furoate—Urticaria—Betamethasone—multiple sclerosis	4.58e-05	0.0011	CcSEcCtD
Fluticasone furoate—Dizziness—Prednisolone—multiple sclerosis	4.57e-05	0.0011	CcSEcCtD
Fluticasone furoate—Body temperature increased—Dexamethasone—multiple sclerosis	4.56e-05	0.0011	CcSEcCtD
Fluticasone furoate—Body temperature increased—Betamethasone—multiple sclerosis	4.56e-05	0.0011	CcSEcCtD
Fluticasone furoate—Cough—Methotrexate—multiple sclerosis	4.48e-05	0.00108	CcSEcCtD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	4.48e-05	0.0329	CbGpPWpGaD
Fluticasone furoate—Rash—Prednisolone—multiple sclerosis	4.35e-05	0.00105	CcSEcCtD
Fluticasone furoate—Dermatitis—Prednisolone—multiple sclerosis	4.35e-05	0.00105	CcSEcCtD
Fluticasone furoate—Diarrhoea—Methylprednisolone—multiple sclerosis	4.34e-05	0.00104	CcSEcCtD
Fluticasone furoate—Headache—Prednisolone—multiple sclerosis	4.33e-05	0.00104	CcSEcCtD
Fluticasone furoate—NR3C1—Endoderm Differentiation—TBX21—multiple sclerosis	4.25e-05	0.0312	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—EOMES—multiple sclerosis	4.25e-05	0.0312	CbGpPWpGaD
Fluticasone furoate—Dizziness—Triamcinolone—multiple sclerosis	4.2e-05	0.00101	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Methotrexate—multiple sclerosis	4.19e-05	0.00101	CcSEcCtD
Fluticasone furoate—Dizziness—Methylprednisolone—multiple sclerosis	4.19e-05	0.00101	CcSEcCtD
Fluticasone furoate—Infection—Methotrexate—multiple sclerosis	4.17e-05	0.001	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Methotrexate—multiple sclerosis	4.11e-05	0.000991	CcSEcCtD
Fluticasone furoate—Nausea—Prednisolone—multiple sclerosis	4.1e-05	0.000988	CcSEcCtD
Fluticasone furoate—Rash—Triamcinolone—multiple sclerosis	4e-05	0.000965	CcSEcCtD
Fluticasone furoate—Dermatitis—Triamcinolone—multiple sclerosis	4e-05	0.000964	CcSEcCtD
Fluticasone furoate—Rash—Methylprednisolone—multiple sclerosis	4e-05	0.000963	CcSEcCtD
Fluticasone furoate—Dermatitis—Methylprednisolone—multiple sclerosis	3.99e-05	0.000962	CcSEcCtD
Fluticasone furoate—Urticaria—Prednisone—multiple sclerosis	3.99e-05	0.00096	CcSEcCtD
Fluticasone furoate—Headache—Triamcinolone—multiple sclerosis	3.98e-05	0.000959	CcSEcCtD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	3.98e-05	0.0292	CbGpPWpGaD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	3.98e-05	0.0292	CbGpPWpGaD
Fluticasone furoate—Headache—Methylprednisolone—multiple sclerosis	3.97e-05	0.000956	CcSEcCtD
Fluticasone furoate—Body temperature increased—Prednisone—multiple sclerosis	3.97e-05	0.000956	CcSEcCtD
Fluticasone furoate—Diarrhoea—Betamethasone—multiple sclerosis	3.94e-05	0.00095	CcSEcCtD
Fluticasone furoate—Diarrhoea—Dexamethasone—multiple sclerosis	3.94e-05	0.00095	CcSEcCtD
Fluticasone furoate—Dizziness—Dexamethasone—multiple sclerosis	3.81e-05	0.000918	CcSEcCtD
Fluticasone furoate—Dizziness—Betamethasone—multiple sclerosis	3.81e-05	0.000918	CcSEcCtD
Fluticasone furoate—Nausea—Triamcinolone—multiple sclerosis	3.77e-05	0.000909	CcSEcCtD
Fluticasone furoate—Nausea—Methylprednisolone—multiple sclerosis	3.76e-05	0.000907	CcSEcCtD
Fluticasone furoate—Dyspnoea—Methotrexate—multiple sclerosis	3.74e-05	0.000901	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Prednisone—multiple sclerosis	3.7e-05	0.000891	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	3.66e-05	0.0268	CbGpPWpGaD
Fluticasone furoate—Rash—Dexamethasone—multiple sclerosis	3.63e-05	0.000875	CcSEcCtD
Fluticasone furoate—Rash—Betamethasone—multiple sclerosis	3.63e-05	0.000875	CcSEcCtD
Fluticasone furoate—Dermatitis—Betamethasone—multiple sclerosis	3.63e-05	0.000875	CcSEcCtD
Fluticasone furoate—Dermatitis—Dexamethasone—multiple sclerosis	3.63e-05	0.000875	CcSEcCtD
Fluticasone furoate—Headache—Betamethasone—multiple sclerosis	3.61e-05	0.00087	CcSEcCtD
Fluticasone furoate—Headache—Dexamethasone—multiple sclerosis	3.61e-05	0.00087	CcSEcCtD
Fluticasone furoate—Diarrhoea—Prednisone—multiple sclerosis	3.43e-05	0.000827	CcSEcCtD
Fluticasone furoate—Nausea—Betamethasone—multiple sclerosis	3.42e-05	0.000825	CcSEcCtD
Fluticasone furoate—Nausea—Dexamethasone—multiple sclerosis	3.42e-05	0.000825	CcSEcCtD
Fluticasone furoate—Urticaria—Methotrexate—multiple sclerosis	3.33e-05	0.000803	CcSEcCtD
Fluticasone furoate—Dizziness—Prednisone—multiple sclerosis	3.32e-05	0.000799	CcSEcCtD
Fluticasone furoate—Body temperature increased—Methotrexate—multiple sclerosis	3.32e-05	0.000799	CcSEcCtD
Fluticasone furoate—NR3C1—Nuclear Receptors—PGR—multiple sclerosis	3.17e-05	0.0233	CbGpPWpGaD
Fluticasone furoate—Rash—Prednisone—multiple sclerosis	3.16e-05	0.000762	CcSEcCtD
Fluticasone furoate—Dermatitis—Prednisone—multiple sclerosis	3.16e-05	0.000762	CcSEcCtD
Fluticasone furoate—Headache—Prednisone—multiple sclerosis	3.14e-05	0.000757	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Methotrexate—multiple sclerosis	3.09e-05	0.000744	CcSEcCtD
Fluticasone furoate—Nausea—Prednisone—multiple sclerosis	2.98e-05	0.000718	CcSEcCtD
Fluticasone furoate—Diarrhoea—Methotrexate—multiple sclerosis	2.87e-05	0.000691	CcSEcCtD
Fluticasone furoate—NR3C1—Endoderm Differentiation—PABPC1—multiple sclerosis	2.8e-05	0.0206	CbGpPWpGaD
Fluticasone furoate—Dizziness—Methotrexate—multiple sclerosis	2.77e-05	0.000668	CcSEcCtD
Fluticasone furoate—Rash—Methotrexate—multiple sclerosis	2.64e-05	0.000637	CcSEcCtD
Fluticasone furoate—Dermatitis—Methotrexate—multiple sclerosis	2.64e-05	0.000636	CcSEcCtD
Fluticasone furoate—Headache—Methotrexate—multiple sclerosis	2.63e-05	0.000633	CcSEcCtD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	2.51e-05	0.0184	CbGpPWpGaD
Fluticasone furoate—Nausea—Methotrexate—multiple sclerosis	2.49e-05	0.0006	CcSEcCtD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	2.45e-05	0.018	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	2.45e-05	0.018	CbGpPWpGaD
Fluticasone furoate—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	2.27e-05	0.0166	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptors—VDR—multiple sclerosis	2.22e-05	0.0162	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	2.17e-05	0.0159	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	2.1e-05	0.0154	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	1.86e-05	0.0136	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	1.75e-05	0.0128	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—C4A—multiple sclerosis	1.72e-05	0.0126	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	1.56e-05	0.0114	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	1.56e-05	0.0114	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	1.54e-05	0.0113	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	1.54e-05	0.0113	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	1.52e-05	0.0112	CbGpPWpGaD
Fluticasone furoate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	1.5e-05	0.011	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	1.43e-05	0.0105	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	1.41e-05	0.0103	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	1.4e-05	0.0103	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	1.4e-05	0.0103	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	1.4e-05	0.0102	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	1.32e-05	0.0097	CbGpPWpGaD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.3e-05	0.00954	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	1.29e-05	0.00943	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	1.28e-05	0.00937	CbGpPWpGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	1.27e-05	0.00932	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	1.26e-05	0.00925	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	1.26e-05	0.00925	CbGpPWpGaD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	1.24e-05	0.00906	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	1.21e-05	0.00887	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	1.2e-05	0.00884	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	1.18e-05	0.00863	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	1.17e-05	0.00855	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	1.13e-05	0.00831	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	1.09e-05	0.00802	CbGpPWpGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	1.03e-05	0.00752	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	9.49e-06	0.00696	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CD28—multiple sclerosis	9.22e-06	0.00676	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	9.14e-06	0.00671	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	9e-06	0.0066	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	8.82e-06	0.00647	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	8.75e-06	0.00641	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CD40—multiple sclerosis	8.41e-06	0.00617	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	8.29e-06	0.00608	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	8.23e-06	0.00604	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.02e-06	0.00588	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	7.77e-06	0.0057	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	7.58e-06	0.00556	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	7.3e-06	0.00535	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	7.29e-06	0.00535	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—FAS—multiple sclerosis	7.22e-06	0.0053	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	6.96e-06	0.00511	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	6.91e-06	0.00507	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—ZNF746—multiple sclerosis	6.91e-06	0.00507	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	6.85e-06	0.00502	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	6.83e-06	0.00501	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.7e-06	0.00491	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.7e-06	0.00491	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.61e-06	0.00484	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.61e-06	0.00484	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CD86—multiple sclerosis	6.58e-06	0.00482	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	6.54e-06	0.0048	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	6.45e-06	0.00473	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL10—multiple sclerosis	6.45e-06	0.00473	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PTBP1—multiple sclerosis	6.32e-06	0.00463	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL4—multiple sclerosis	6.27e-06	0.0046	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	6.13e-06	0.0045	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	6.09e-06	0.00446	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—FAS—multiple sclerosis	5.78e-06	0.00424	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	5.75e-06	0.00421	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	5.68e-06	0.00417	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	5.52e-06	0.00404	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	5.4e-06	0.00396	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	5.39e-06	0.00395	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	5.19e-06	0.00381	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	4.81e-06	0.00353	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.8e-06	0.00352	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—U2AF2—multiple sclerosis	4.79e-06	0.00351	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	4.79e-06	0.00351	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	4.66e-06	0.00341	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	4.33e-06	0.00317	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.27e-06	0.00313	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.15e-06	0.00304	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	4.06e-06	0.00298	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.86e-06	0.00283	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.79e-06	0.00278	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	3.78e-06	0.00278	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	3.65e-06	0.00268	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	3.58e-06	0.00262	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—STAT3—multiple sclerosis	3.54e-06	0.0026	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.5e-06	0.00257	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.38e-06	0.00248	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.37e-06	0.00247	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.33e-06	0.00244	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	3.28e-06	0.00241	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.24e-06	0.00237	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—TNF—multiple sclerosis	3.07e-06	0.00225	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	3.02e-06	0.00222	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PABPC1—multiple sclerosis	2.93e-06	0.00215	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.85e-06	0.00209	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.84e-06	0.00208	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.65e-06	0.00194	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—RPL5—multiple sclerosis	2.65e-06	0.00194	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SRM—multiple sclerosis	2.64e-06	0.00194	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.63e-06	0.00193	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.56e-06	0.00188	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—IL6—multiple sclerosis	2.47e-06	0.00181	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.45e-06	0.0018	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.26e-06	0.00166	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.14e-06	0.00157	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PGR—multiple sclerosis	2.08e-06	0.00153	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.86e-06	0.00136	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.86e-06	0.00136	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GPC5—multiple sclerosis	1.7e-06	0.00125	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SRM—multiple sclerosis	1.63e-06	0.00119	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.51e-06	0.0011	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—VDR—multiple sclerosis	1.46e-06	0.00107	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—RRM1—multiple sclerosis	1.41e-06	0.00103	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.3e-06	0.000953	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.3e-06	0.000951	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.27e-06	0.000933	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.21e-06	0.000888	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	1.2e-06	0.000882	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.15e-06	0.00084	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.15e-06	0.00084	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.05e-06	0.000768	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.68e-07	0.000637	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.14e-07	0.000597	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—BCHE—multiple sclerosis	8.09e-07	0.000593	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MYC—multiple sclerosis	5.79e-07	0.000424	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.99e-07	0.000366	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—APOE—multiple sclerosis	4.87e-07	0.000357	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—POMC—multiple sclerosis	4.18e-07	0.000307	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ALB—multiple sclerosis	3.81e-07	0.00028	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—APOE—multiple sclerosis	3e-07	0.00022	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—POMC—multiple sclerosis	2.58e-07	0.000189	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ALB—multiple sclerosis	2.35e-07	0.000172	CbGpPWpGaD
